108 related articles for article (PubMed ID: 32028326)
1. Early scale-up of antiretroviral therapy at diagnosis for reducing economic burden of cardiometabolic disease in HIV-infected population.
Yang CT; Toh HS; Liao CT; Kuo S; Ou HT; Ko NY
AIDS; 2020 May; 34(6):903-911. PubMed ID: 32028326
[TBL] [Abstract][Full Text] [Related]
2. Association of adherence to antiretroviral therapy with economic burden of cardiovascular disease in HIV-infected population.
Liao CT; Yang CT; Chen PH; Toh HS; Kuo S; Chen ZC; Ou HT; Ko NY; Wang JD
Eur J Prev Cardiol; 2021 Apr; 28(3):326-334. PubMed ID: 33891692
[TBL] [Abstract][Full Text] [Related]
3. Reduced economic burden of AIDS-defining illnesses associated with adherence to antiretroviral therapy.
Toh HS; Yang CT; Yang KL; Ku HC; Liao CT; Kuo S; Tang HJ; Ko WC; Ou HT; Ko NY
Int J Infect Dis; 2020 Feb; 91():44-49. PubMed ID: 31740407
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.
Osoti A; Temu TM; Kirui N; Ngetich EK; Kamano JH; Page S; Farquhar C; Bloomfield GS
AIDS Patient Care STDS; 2018 Jun; 32(6):215-222. PubMed ID: 29851503
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and related drug cost of comorbidities in HIV-infected patients receiving highly active antiretroviral therapy in Taiwan: A cross-sectional study.
Yang CJ; Wang HY; Chou TC; Chang CJ
J Microbiol Immunol Infect; 2019 Oct; 52(5):720-727. PubMed ID: 31358463
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV- infected adults initiating antiretroviral therapy in Urban Tanzania.
Mwakyandile TM; Shayo GA; Sasi PG; Mugusi FM; Barabona G; Ueno T; Lyamuya EF
BMC Cardiovasc Disord; 2023 Jun; 23(1):309. PubMed ID: 37340390
[TBL] [Abstract][Full Text] [Related]
7. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
8. Nutrition indicators as potential predictors of AIDS-defining illnesses among ARV-naïve HIV-positive adults in Kapiri Mposhi, Zambia 2008-2009.
Chen YN; Wall KM; Fofana K; Navarro-Colorado C
PLoS One; 2019; 14(7):e0219111. PubMed ID: 31265479
[TBL] [Abstract][Full Text] [Related]
9. Effects of antiretroviral treatment and nadir CD4 count in progression to cardiovascular events and related comorbidities in a HIV Brazilian cohort: a multi-stage approach.
Oliveira RVC; Shimakura SE; Campos DP; Hökerberg YHM; Victoriano FP; Ribeiro S; Veloso VG; Grinsztejn B; Carvalho MS
AIDS Care; 2018 May; 30(5):551-559. PubMed ID: 29058481
[TBL] [Abstract][Full Text] [Related]
10. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
Grinsztejn B; Veloso VG; Pilotto JH; Campos DP; Keruly JC; Moore RD
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):515-20. PubMed ID: 17558332
[TBL] [Abstract][Full Text] [Related]
12. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services.
Divala OH; Amberbir A; Ismail Z; Beyene T; Garone D; Pfaff C; Singano V; Akello H; Joshua M; Nyirenda MJ; Matengeni A; Berman J; Mallewa J; Chinomba GS; Kayange N; Allain TJ; Chan AK; Sodhi SK; van Oosterhout JJ
BMC Public Health; 2016 Dec; 16(1):1243. PubMed ID: 27955664
[TBL] [Abstract][Full Text] [Related]
13. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy.
Raposo MA; Armiliato GNA; Guimarães NS; Caram CA; Silveira RDS; Tupinambás U
Rev Soc Bras Med Trop; 2017; 50(5):598-606. PubMed ID: 29160505
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
[TBL] [Abstract][Full Text] [Related]
15. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.
Glass TR; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC;
HIV Clin Trials; 2007; 8(2):77-85. PubMed ID: 17507323
[TBL] [Abstract][Full Text] [Related]
16. AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database.
Zhou J; Paton NI; Ditangco R
Int J STD AIDS; 2007 Jul; 18(7):446-52. PubMed ID: 17623500
[TBL] [Abstract][Full Text] [Related]
17. Patterns of diagnoses in hospital admissions in a multistate cohort of HIV-positive adults in 2001.
Betz ME; Gebo KA; Barber E; Sklar P; Fleishman JA; Reilly ED; Christopher Mathews W;
Med Care; 2005 Sep; 43(9 Suppl):III3-14. PubMed ID: 16116304
[TBL] [Abstract][Full Text] [Related]
18. Causes of death in the era of highly active antiretroviral therapy: a retrospective analysis of a hybrid hematology-oncology and HIV practice and the Seattle/King county adult/adolescent spectrum of HIV-related diseases project.
Uhlenkott MC; Buskin SE; Kahle EM; Barash E; Aboulafia DM
Am J Med Sci; 2008 Sep; 336(3):217-23. PubMed ID: 18794615
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Disease Prevention Policy in Human Immunodeficiency Virus: Recommendations From a Modeling Study.
Smit M; van Zoest RA; Nichols BE; Vaartjes I; Smit C; van der Valk M; van Sighem A; Wit FW; Hallett TB; Reiss P;
Clin Infect Dis; 2018 Feb; 66(5):743-750. PubMed ID: 29029103
[TBL] [Abstract][Full Text] [Related]
20. Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.
Rotger M; Bayard C; Taffé P; Martinez R; Cavassini M; Bernasconi E; Battegay M; Hirschel B; Furrer H; Witteck A; Weber R; Ledergerber B; Telenti A; Tarr PE;
Circ Cardiovasc Genet; 2009 Dec; 2(6):621-8. PubMed ID: 20031643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
